Alkem Laboratories Limited announced that its board of directors approved the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. The board meeting was held on May 28, 2026.
The board recommended a final dividend of Rs 10 per equity share for the financial year ended March 31, 2026. Each equity share has a face value of Rs 2. The dividend proposal will be placed before shareholders for approval at the annual general meeting.
Alkem Laboratories fixed August 7, 2026 as the record date for determining shareholder eligibility for the final dividend. If declared by shareholders at the AGM, payment of the dividend will commence from September 1, 2026.
The 52nd annual general meeting of Alkem Laboratories will be held on August 27, 2026. Alkem Laboratories had earlier informed the stock exchanges on May 19, 2026 that the board would meet to consider the results and dividend.
The board approved the re-appointment of Mrs. Madhurima Singh as an Executive Director for a term of five consecutive years from December 20, 2026 to December 19, 2031. The re-appointment is based on the recommendations of the Nomination and Remuneration Committee and the Audit Committee and is subject to shareholder approval at the AGM.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.